Jonathan C. Javitt

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Wilmington, DE
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jonathan Javitt
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jonathan C. Javitt

Form 4 holding Chairman and Chief Scientist, Director, 10%+ Owner

NRX Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,260,000
Estimated value
$1,474,200
Report date
17 Dec 2024
Price
$1.17
Ownership
By the Jonathan Javitt Living Trust
Form 4 holding Chairman and Chief Scientist, Director, 10%+ Owner

NRX Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
142,200
Estimated value
$166,374
Report date
17 Dec 2024
Price
$1.17
Ownership
By the Javitt 2012 Irrevocable Dynasty Trust
Form 4 holding Chairman and Chief Scientist, Director, 10%+ Owner

NRX Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
84,634
Estimated value
$99,022
Report date
17 Dec 2024
Price
$1.17
Ownership
Direct
Form 4 holding Chairman and Chief Scientist, Director, 10%+ Owner

NRX Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
30,000
Estimated value
$35,100
Report date
17 Dec 2024
Price
$1.17
Ownership
By the Jonathan Javitt Donor Advised Fund
Form 4 holding Chairman and Chief Scientist, Director, 10%+ Owner

NRX Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
125,000
Estimated value
Report date
09 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jonathan C. Javitt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .